Last 48 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 33.58 | 46.43 | 3.44 | 86.80 | — | 116.51 | — | — | 3.54 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -60.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 8.16 | 6.41 | 2.88 | 1.96 | 2.22 | 1.95 | 3.06 | 2.90 | 3.60 | 4.98 | 2.20 | 1.90 | 2.41 | 1.41 | 1.63 | 1.59 | 1.85 | 2.87 | 3.55 | 6.17 | 7.59 |
| — | +228.4% | -5.7% | -32.3% | -38.3% | -60.8% | +39.4% | +52.5% | +49.2% | +253.2% | +34.9% | +19.7% | +30.2% | -50.8% | -54.1% | -74.3% | -75.6% | -74.0% | -78.0% | -52.2% | -50.2% | |
| P/B Ratio | 13.81 | 7.65 | 3.58 | 2.94 | 3.18 | 2.51 | 3.24 | 2.59 | 3.29 | 6.05 | 3.06 | 2.14 | 2.42 | 0.96 | 1.13 | 1.17 | 1.42 | 2.08 | 2.58 | 4.29 | 5.16 |
| — | +204.5% | +10.4% | +13.8% | -3.5% | -58.5% | +5.8% | +21.0% | +36.0% | +528.4% | +171.2% | +83.0% | +70.8% | -53.8% | -56.2% | -72.8% | -72.5% | -70.5% | -74.1% | -42.0% | -59.9% | |
| P/FCF | 67.53 | 80.47 | 13.24 | 448.61 | 12.20 | 5.42 | 29.85 | — | 15.30 | 38.11 | 11.81 | — | — | — | — | — | 39.07 | — | — | — | — |
| — | +1385.3% | -55.6% | — | -20.2% | -85.8% | +152.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 154.84 | 54.72 | 67.84 | 30.53 | — | 36.48 | — | — | 3.65 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +50.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 78.39 | 1136.34 | 120.82 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.6% | 71.1% | 73.5% | 71.4% | 67.2% | 69.4% | 66.9% | 66.4% | 67.5% | 66.7% | 69.7% | 64.0% | 60.9% | 63.5% | 63.2% | 66.4% | 64.2% | 64.3% | 65.8% | 66.2% | 65.9% |
| — | +2.5% | +9.8% | +7.5% | -0.3% | +3.9% | -3.9% | +3.8% | +10.7% | +5.1% | +10.3% | -3.6% | -5.1% | -1.3% | -4.1% | +0.4% | -2.6% | -4.2% | -2.7% | -2.7% | -2.8% | |
| Operating Margin | -6.6% | 5.8% | 0.2% | 1.5% | -5.6% | -0.2% | -12.4% | -9.5% | 86.3% | -12.7% | -7.9% | -26.8% | -187.0% | -42.8% | -39.3% | -31.5% | -23.2% | -21.8% | -26.9% | -24.0% | -19.4% |
| — | +2467.1% | +101.6% | +116.1% | -106.5% | +98.1% | -56.5% | +64.7% | +146.1% | +70.4% | +79.8% | +14.8% | -705.9% | -96.1% | -45.9% | -31.2% | -19.4% | -89.2% | -321.4% | -1784.6% | -271.7% | |
| Net Margin | -5.6% | 13.8% | 83.8% | 2.4% | -3.8% | 1.7% | -9.9% | -12.2% | 90.1% | -8.9% | -5.0% | -23.1% | -180.1% | -35.0% | -35.5% | -30.7% | -22.2% | -21.3% | -26.9% | -24.7% | -20.4% |
| — | +726.9% | +948.3% | +119.5% | -104.2% | +118.7% | -97.3% | +47.1% | +150.0% | +74.4% | +85.9% | +24.8% | -709.5% | -63.7% | -31.9% | -24.2% | -9.1% | -35.6% | -935.9% | -2327.2% | -240.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -6.3% | 4.3% | 29.9% | 0.9% | -1.3% | 0.5% | -2.4% | -2.7% | 23.9% | -2.8% | -1.8% | -6.4% | -36.0% | -5.9% | -6.0% | -5.6% | -4.2% | -3.8% | -4.8% | -4.3% | -3.4% |
| — | +723.4% | +1334.7% | +133.3% | -105.6% | +119.1% | -36.6% | +57.6% | +166.4% | +53.1% | +70.6% | -15.3% | -752.8% | -52.7% | -25.6% | -31.2% | -22.7% | -54.0% | -1088.8% | -2220.3% | -167.6% | |
| ROA | -4.7% | 3.3% | 23.4% | 0.7% | -1.0% | 0.4% | -1.8% | -2.1% | 16.1% | -1.6% | -1.0% | -3.6% | -24.4% | -4.6% | -4.8% | -4.4% | -3.4% | -3.1% | -4.0% | -3.5% | -2.9% |
| — | +759.6% | +1377.4% | +132.3% | -106.0% | +124.3% | -82.4% | +41.7% | +166.1% | +66.0% | +79.0% | +18.3% | -623.9% | -48.2% | -20.0% | -25.6% | -17.9% | -46.9% | -1036.9% | -2237.5% | -193.7% | |
| ROIC | -6.8% | 3.8% | 0.1% | 0.5% | -1.8% | -0.1% | -2.7% | -2.0% | 22.4% | -3.9% | -2.8% | -7.1% | -32.5% | -6.1% | -5.6% | -4.8% | -3.7% | -3.8% | -5.4% | -6.4% | -8.3% |
| — | +5667.8% | +104.4% | +126.2% | -107.9% | +98.2% | +4.4% | +72.3% | +169.0% | +36.8% | +50.7% | -48.2% | -775.6% | -61.8% | -3.9% | +25.6% | +55.1% | +11.8% | -165.7% | -1622.0% | -321.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.06 | 0.05 | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 | 0.07 | 0.11 | 0.12 | 0.13 | 0.13 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.04 | 0.04 | 0.05 |
| — | -30.2% | -49.2% | -2.1% | +15.3% | -19.0% | -25.1% | -37.9% | -42.8% | +22.8% | +32.3% | +43.1% | +44.7% | -2.3% | +109.1% | +101.3% | +97.5% | +98.9% | -2.5% | -2.5% | -29.7% | |
| Debt / EBITDA | — | 1.89 | 4.47 | 3.44 | — | 5.62 | — | — | 0.36 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -66.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.86 | 2.31 | 4.58 | 3.40 | 2.86 | 3.03 | 3.30 | 4.11 | 3.94 | 4.10 | 4.09 | 4.32 | 4.02 | 4.75 | 4.84 | 5.17 | 5.10 | 5.52 | 5.15 | 6.15 | 5.61 |
| — | -23.7% | +38.9% | -17.1% | -27.3% | -26.1% | -19.4% | -4.9% | -2.0% | -13.6% | -15.5% | -16.5% | -21.3% | -14.0% | -5.9% | -15.9% | -8.9% | -13.4% | -34.3% | -35.9% | +42.1% | |
| Quick Ratio | 2.56 | 2.25 | 4.51 | 3.07 | 2.56 | 2.75 | 3.00 | 3.84 | 3.72 | 3.87 | 3.85 | 4.03 | 3.77 | 4.50 | 4.59 | 4.92 | 4.85 | 5.27 | 4.91 | 5.88 | 5.38 |
| — | -18.2% | +50.3% | -20.0% | -31.0% | -29.0% | -22.1% | -4.8% | -1.3% | -14.1% | -16.2% | -18.1% | -22.3% | -14.5% | -6.5% | -16.3% | -9.9% | -13.8% | -35.2% | -36.8% | +41.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CDNA stock.
CareDx, Inc's current P/E is 33.6x. The average P/E over the last 3 quarters is 45.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
CareDx, Inc's current operating margin is -6.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CareDx, Inc's business trajectory between earnings reports.